Literature DB >> 8143469

Use of arterial blood with bedside glucose reflectance meters in an intensive care unit: are they accurate?

R E Maser1, M A Butler, G S DeCherney.   

Abstract

OBJECTIVE: To compare blood glucose values obtained from two different sampling sites (arterial catheter and capillary from finger puncture), which were analyzed by a bedside reflectance meter. A sample was also analyzed by standard methods (oxygen electrode oxidation in the laboratory).
DESIGN: Prospective, cross-sectional clinical study.
SETTING: Cardiovascular intensive care unit (ICU) designed for postoperative open-heart surgery patients in a 1,100-bed medical center. PATIENTS: Sequential sample of 50 patients immediately after open-heart surgery.
MEASUREMENTS AND MAIN RESULTS: The blood glucose concentration of each patient was analyzed on the patient's arrival to the ICU (immediately postoperatively) by three methods: one blood specimen was obtained from an arterial catheter, divided and analyzed either at the bedside by a reflectance meter (glucose method 1) or in the hospital laboratory (glucose method 2); another sample was obtained by lancing the fingertip and the glucose concentration was analyzed at the bedside in the same reflectance meter (glucose method 3). Using paired analyses to compare the mean glucose values of the bedside arterial whole blood sample (method 1) with the arterial serum sample (method 2) demonstrated that the glucose concentration in the arterial whole blood sample (method 1) was significantly (p < .001) higher. For 46 of 50 comparisons, the glucose value in the arterial whole blood sample (method 1) was higher, with a mean difference of 30 mg/dL (1.7 mmol/L). Although the mean difference was reduced to 10 mg/dL (0.6 mmol/L) when the arterial whole blood sample (method 1) was corrected for the hematocrit (i.e., < 35% [< 0.35]), the mean glucose concentration in the arterial whole blood samples (method 1) remained statistically higher (p < .05). The glucose concentration in the arterial serum sample (method 2) was significantly higher than the value determined from the bedside capillary sample (method 3) before (p < .05) and after (p < .001) correction for hematocrit. The difference in mean glucose concentrations between the arterial serum sample (method 2) and bedside capillary sample (method 3) was 9 mg/dL (0.5 mmol/L) when the capillary specimen (method 3) was not corrected for hematocrit. This difference increased to 21 mg/dL (1.2 mmol/L) when low hematocrit values were considered and appropriate adjustments of the glucose values were made. At the bedside, one can accurately correct arterial whole blood glucose values to correspond to laboratory values by the following formula: (0.94 x arterial whole blood glucose) + (4.6 x hematocrit) + (-16.5 x [37 degrees C--patient's temperature])--132 = laboratory glucose value.
CONCLUSIONS: Since arterial whole blood samples give higher glucose results than arterial serum, the use of arterial whole blood in combination with reflectance meters must be recommended with caution. This caution is especially advised if the glucose values obtained with arterial whole blood are used in conjunction with a sliding scale of insulin, which depends on threshold concentrations of glucose. In our hospital, use of arterial whole blood in combination with reflectance meters could have resulted in an incorrect dose of insulin in 31 of 50 patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8143469     DOI: 10.1097/00003246-199404000-00014

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  11 in total

1.  Intraoperative accuracy of a point-of-care glucose meter compared with simultaneous central laboratory measurements.

Authors:  Boris Mraovic; Eric S Schwenk; Richard H Epstein
Journal:  J Diabetes Sci Technol       Date:  2012-05-01

2.  Impact of High-Dose Intravenous Vitamin C for Treatment of Sepsis on Point-of-Care Blood Glucose Readings.

Authors:  Anna Peyton Howell; Jenna L Parrett; Daniel R Malcom
Journal:  J Diabetes Sci Technol       Date:  2019-11-25

3.  Suitability of capillary blood glucose analysis in patients receiving vasopressors.

Authors:  Myra F Ellis; Kesi Benjamin; Morgan Cornell; Kelsey Decker; Debra Farrell; Lynn McGugan; Gloria P Porter; Helen Shearin; Yanfang Zhao; Bradi B Granger
Journal:  Am J Crit Care       Date:  2013-09       Impact factor: 2.228

Review 4.  Accuracy of point-of-care glucose measurements.

Authors:  Annette Rebel; Mark A Rice; Brenda G Fahy
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

5.  Multicenter Observational Study of the First-Generation Intravenous Blood Glucose Monitoring System in Hospitalized Patients.

Authors:  Grant V Bochicchio; Brian R Hipszer; Michelle F Magee; Richard M Bergenstal; Anthony P Furnary; Angela M Gulino; Michael J Higgins; Peter C Simpson; Jeffrey I Joseph
Journal:  J Diabetes Sci Technol       Date:  2015-06-01

Review 6.  Challenges to glycemic measurement in the perioperative and critically ill patient: a review.

Authors:  Andrew D Pitkin; Mark J Rice
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

Review 7.  An overview of hypoglycemia in the critically ill.

Authors:  Jean-Claude Lacherade; Sophie Jacqueminet; Jean-Charles Preiser
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

Review 8.  Glycemic targets and approaches to management of the patient with critical illness.

Authors:  Dieter Mesotten; Greet Van den Berghe
Journal:  Curr Diab Rep       Date:  2012-02       Impact factor: 4.810

9.  Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients.

Authors:  Anouk M Corstjens; Jack J M Ligtenberg; Iwan C C van der Horst; Rob Spanjersberg; Joline S W Lind; Jaap E Tulleken; John H J M Meertens; Jan G Zijlstra
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

10.  Initial distribution volume of glucose can be approximated using a conventional glucose analyzer in the intensive care unit.

Authors:  Hironori Ishihara; Hitomi Nakamura; Hirobumi Okawa; Hajime Takase; Toshihito Tsubo; Kazuyoshi Hirota
Journal:  Crit Care       Date:  2005-02-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.